In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Santaris Pharma A/S

http://www.santaris.com/

Latest From Santaris Pharma A/S

In Saudi Arabia, A Vision Of Healthcare Spurs Growth

As the Kingdom of Saudi Arabia reduces its dependence on oil as an export, one sector it is building up is the life sciences industry. The government is encouraging global companies to manufacture and invest domestically and they are improving their regulatory system and working with local players to enhance access to patients.

Saudi Arabia Emerging Markets

Remembering Japan Pharma Veteran Bill Bishop

Biopharma sector in Japan and Asia shocked by death of industry veteran and long-time Japan resident Bill Bishop and two family members in violent Christmas Day attack at their home in Saitama.

Japan Asia Pacific

Remembering Japan Pharma Veteran Bill Bishop

Biopharma sector in Japan and Asia shocked by death of industry veteran and long-time Japan resident Bill Bishop and two family members in violent Christmas Day attack at their home in Saitama.

Japan Asia Pacific

Pfizer Leads An Unusual Year For The Scrip 100

Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.

Outlook 2023 Sales & Earnings
See All

Company Information

UsernamePublicRestriction

Register